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Feline coronavirus (FCoV) infections are endemic among cats worldwide. The majority of
infections are asymptomatic or result in only mild enteric disease. However, approximately 5% of
cases develop feline infectious peritonitis (FIP), a systemic disease that is a frequent cause of
death in young cats. In this study, we report the complete coding genome sequences of six
FCoVs: three from faecal samples from healthy cats and three from tissue lesion samples from
cats with confirmed FIP. The six samples were obtained over a period of 8 weeks at a single-site
cat rescue and rehoming centre in the UK. We found amino acid differences located at 44
positions across an alignment of the six virus translatomes and, at 21 of these positions, the
differences fully or partially discriminated between the genomes derived from the faecal samples
and the genomes derived from the tissue lesion samples. In this study, two amino acid differences
fully discriminated the two classes of genomes: these were both located in the S2 domain of the
virus surface glycoprotein gene. We also identified deletions in the 3c protein ORF of genomes
from two of the FIP samples. Our results support previous studies that implicate S protein
mutations in the pathogenesis of FIP.
INTRODUCTION
Coronaviruses are enveloped, positive-sense RNA viruses.
They are generally responsible for mild enteric and respira-
tory infections, but they can also be associated with severe
disease in both humans and animals (Masters & Perlman,
2013). Coronaviruses are now recognized as emerging
viruses with a propensity to cross into new host species, as
has been shown by the recent outbreaks of severe acute
respiratory syndrome andMiddle East respiratory syndrome
(Coleman & Frieman, 2014). As illustrated in Fig. 1 for feline
coronavirus (FCoV), two-thirds of the coronavirus genome
encodes proteins involved in viral RNA synthesis. The
majority of these proteins are encoded in two 59-proximal,
overlapping ORFs, ORF1a and ORF1b, and are translated as
the polyproteins pp1a and pp1ab, which are then processed
by virus-encoded proteinases into 16 non-structural pro-
teins (Ziebuhr, 2005). The remainder of the genome encodes
the virus structural proteins (S, E, M and N), as well as
accessory proteins that are not essential for replication in cell
culture. The structural and accessory proteins are translated
from a 39 co-terminal nested set of subgenomic mRNAs
(Perlman & Netland, 2009).
The coronavirus surface or spike (S) glycoprotein is a typical
class 1 viral fusion protein and has a central role in the
biology of coronavirus infection. Structurally, the protein
can be divided in to an amino-proximal half, the S1 domain,
which contains the receptor-binding domain, and a carboxyl-
proximal half, the S2 domain, which contains elements
involved inmembrane fusion. These elements include heptad
repeats, a fusion peptide and a carboxyl-terminal, hydro-
phobic transmembrane domain (Heald-Sargent & Gallagher,
2012). In many coronaviruses, the S1 and S2 domains are
cleaved from each other by a cellular, furin-like enzyme
(de Haan et al., 2004). The S protein is also the location of
both B- and T-cell epitopes that are important in virus
neutralization and the recognition of virus-infected cells
(Reguera et al., 2012; Satoh et al., 2011).
In this paper, unless otherwise stated, FCoV will be used to mean
serotype 1 FCoV. FCoV is also used as a strain designation for
the species Alphacoronavirus 1 in the genus Alphacoronavirus, family
Coronaviridae.
The GenBank/EMBL/DDBJ accession numbers for the FCoV genomes
reported in this study are KP143511 (80F), KP143509 (65F),
KP143510 (67F), KP143512 (26M), KP143507 (27C) and
KP143508 (28O).
One supplementary figure is available with the online Supplementary
Material.
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FCoVs form two antigenically distinct serotypes: serotype 1,
which is difficult to propagate in cell culture, and serotype 2,
which is the consequence of a double recombination
between type 1 FCoV and canine coronavirus (Herrewegh
et al., 1998) and is relatively easy to propagate in cell culture.
FCoV infections are endemic among cats worldwide, and
serological and molecular studies confirm that serotype 1
FCoVs predominate (Pedersen, 2014b). In the UK, about
40% of domestic cats have been infected with FCoV, and in
multi-cat households, this figure increases to almost 90%
(Addie, 2000; Addie & Jarrett, 1992). The majority of FCoV
infections are asymptomatic or result in only mild enteric
disease. However, approximately 5% of infected cats develop
feline infectious peritonitis (FIP), a systemic inflammatory
disease that is a frequent cause of death in young cats (Kipar
& Meli, 2014). Currently, there is no protective vaccine or
effective treatment for FIP (Pedersen, 2009, 2014a).
The most important questions in FCoV research are why
some infected animals remain relatively healthy whilst
others develop FIP, and what the role of the virus is in the
development of disease. It is now widely accepted that, in
the vast majority of cases, cats are infected by the faecal–
oral route with avirulent FCoV strains circulating in the cat
population. Initially, this virus replicates predominantly
in the intestinal epithelium and is shed with the faeces.
Nonetheless, it often leads to systemic infection via monocyte-
associated viraemia (Kipar et al., 2010; Meli et al., 2004;
Porter et al., 2014). At this stage, however, the systemic
infection is characterized by a relatively low level of virus
replication and infection can be maintained for a prolonged
period of time, possibly involving recurrent viraemic events,
without apparent disease (Kipar et al., 2010). During
replication in the intestine or, potentially, within monocytes/
macrophages (Pedersen et al., 2012), the virus undergoes
mutation, and viruses with an enhanced tropism for mono-
cytes and macrophages emerge. The altered tropism of these
mutants results in their ability to maintain effective and
sustainable replication in monocytes (Dewerchin et al.,
2005). As a direct or indirect result of a higher level of virus
replication, this now apparently virulent virus leads to
activation of monocytes (Regan et al., 2009), which can then
interact with endothelial cells. This, in turn, mediates
granulomatous phlebitis and periphlebitis, the morpho-
logical hallmark and initiating lesion of FIP (Kipar et al.,
2005).
In addition to the virus, the susceptibility of the individual
infected cat to disease also plays a significant role, and it
has been shown that age, breed, gender, reproductive status
and immune response influence the development of FIP
(Pedersen, 2014b; Pedersen et al., 2014). For example, the
efficacy of early T-cell responses critically determines the
disease outcome in cats that have been infected experimen-
tally with a virulent serotype 2 strain, FIPV 79-1146 (de
Groot-Mijnes et al., 2005). Furthermore, there is individual
variation in the susceptibility of a cat’s monocytes to FCoV
(Dewerchin et al., 2005). Also, recently, single-nucleotide
polymorphisms in the feline IFN-c gene have been linked to
both resistance and susceptibility to the development of FIP
(Hsieh & Chueh, 2014). Clearly, unravelling the relationship
between FCoV genotypes and phenotypes and the complex
interactions between the virus and host during the
development of FIP remains a major challenge.
One facet of this challenge is to determine the mutations
that alter the tropism and virulence of FCoV. As a first step,
this can be done by comparing the genomic sequences of
viruses shed in the faeces of healthy animals and viruses
that predominate within tissue lesions of cats that have
been diagnosed with FIP. This approach assumes that the
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Fig. 1. Genomic organization of FCoV. Genomic ORFs are shown as boxes. Only pp1ab is shown as a translation product of
the genomic RNA. The non-structural proteins nsp1–11 are translated from ORF1a (dark grey shading) and translation of the
ORF1b proteins (nsp12–16) occurs following ”1 ribosomal frameshifting (RFS). The nsp11 protein is not depicted as it
represents a short (9 aa) carboxyl extension of nsp10. nsp9, ssRNA-binding protein (ssRBP); nsp12, RNA-dependent RNA
polymerase (RdRp); nsp13, helicase (Hel) and NTPase; nsp14, 39A59 exoribonuclease (ExoN) and N7-methyltransferase (N7-
MT); nsp15, uridylate-specific endonuclease (NendoU); nsp16, 29-O-methyltransferase (29-OMT).
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most highly abundant genome in a population is respon-
sible for a particular disease phenotype, which is consistent
with our current understanding of FIP epidemiology.
Using this approach, a recent study by Chang et al. (2012)
provided evidence for an association between FCoV viru-
lence and amino acid substitutions within the putative
fusion peptide of the FCoV S protein. A more detailed
examination of samples from FCoV-infected cats that did
not have histopathological evidence of FIP led Porter et al.
(2014) to conclude that these substitutions were indicative
of systemic spread, rather than a virus that, without further
mutation, is able to cause FIP. As the S protein fusion
peptide is involved in the fusion of viral and cellular
membranes during virus entry, it seems plausible that
changes within this region may be linked to the tropism of
the virus.
Similarly, Licitra et al. (2013) were able to distinguish
between FCoVs in cats with and without FIP on the basis of
one or more substitutions in the amino acid sequence that
comprises the furin cleavage site within the FCoV S pro-
tein. The authors demonstrated that these substitutions
modulated furin cleavage and suggested that a possible
consequence of the identified substitutions was an enhanced
cleavability by alternative, monocyte/macrophage-specific
proteases.
Finally, there have been many reports over the years of
point mutations and indels in the accessory protein genes
of FCoVs and claims that these may be linked to the
development of FIP. Prominent among these are reports
that truncating and non-truncating mutations in the
ORF3c gene occur in a significant proportion of but not
all FCoVs associated with FIP (Chang et al., 2010; Pedersen
et al., 2012). However, the role of the FCoV 3c protein and
any relationship to the development of FIP is still unclear.
One view is that functional 3c protein expression is
essential for replication in the gut but is dispensable for
systemic replication. Thus, once the virus has left the gut,
there is no further selection pressure to maintain an intact
3c gene and mutations will accumulate over time. This
interpretation does not exclude the possibility that loss or
alteration of the 3c protein may enhance the fitness of the
virus in the monocyte/macrophage environment, but this
is not yet supported by any convincing evidence. Similarly,
whilst the genes encoding the 3a, 3b, 7a and 7b proteins
clearly have important functions that will impact on virus
fitness (Haijema et al., 2004), there is, as yet, no evidence
that links specific mutations in these genes to the
development of FIP.
In this study, we report the genome sequences of six
FCoVs: three from faecal samples from healthy cats and
three from tissue lesion samples from cats with confirmed
FIP. The six samples were obtained from cats that were
resident at a single-site cat rescue and rehoming centre in
the UK. Our results support and extend previous studies
that implicate S protein mutations in the pathogenesis of
FIP.
RESULTS
FCoV RNA in faecal and tissue lesion samples
As a first step, we amplified the FCoV RNA in faecal and
tissue lesion samples. The seven amplicons for each of the
faecal-derived RNA samples were of the expected size and
were produced in approximately equal amounts. In com-
parison, there was greater heterogeneity in the amplicons
obtained from RNA isolated from the FIP tissue lesions
(Fig. 2). Specifically, there was more evidence of non-
specific products and, especially in the case of amplicon 6,
which encompasses the region of the genome encoding the
S protein gene, there was less product than expected. In
this context, we noted that the cycle threshold (Ct) values
were generally higher (i.e. less viral RNA) for faecal samples
than for samples from the FIP tissue lesions. The mean Ct
values for the 65F, 67F and 80F faecal total RNA samples
were 20.9, 16.9 and 29.0, respectively, and for the 26M, 27C
and 28O tissue lesion samples were 14.0, 21.5 and 15.0,
respectively. One explanation for the difference in homo-
geneity of amplicons derived from faecal and lesional
samples may be that the samples derived from lesions
contained significantly greater amounts of FCoV subgen-
omic mRNA than the faecal samples, which would be
expected to contain mainly virion particles. Also, immuno-
histochemistry identified a large number of macrophages
with abundant viral antigen (i.e. N protein) within the
lesions (data not shown). It is therefore very likely that the
RNA extracted from the lesions contained much more viral
mRNA than the faeces. Thus, in the reverse transcription
(RT)-PCRs that involved RNA from tissues, many of the
oligonucleotide primers would bind to multiple templates,
resulting in a more complex amplicon pattern.
Assembly of genome sequences
Using the methods described, we were able to obtain full
genome coverage, with a minimum depth of 1000 reads at
each base across the coding region (Fig. 3). We expect that,
with further optimization, it would be possible to obtain an
acceptable level of coverage and depth for more than four
complete genomes per single 316v2 chip (see Methods).
Similarly, it would also be possible to obtain a very high
density of reads for a single genome if, for example, the
goal was to investigate the nature of the viral quasispecies
in a particular sample. In our opinion, the limiting step in
genome sequencing from clinical samples is the production
of amplicons, but, once this has been achieved, the
downstream processing is relatively straightforward.
Our approach was based on the alignment of sequence
reads with a de novo-assembled target genome and this is
dependent on a relatively high similarity between samples.
For example, in the case of the 65F, 67F, 26M and 28O
samples, the percentages of reads that aligned with the 80F
target genome were 96, 95, 90 and 95%, respectively.
However, only 76.8% of reads from the 27C sample
aligned with the 80F target genome. Thus, for the 27C
C. S. Lewis and others
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sample, the de novo assembly method had to be used. De
novo assembly is more time consuming and would not be a
good approach if every sample had to be analysed in this
manner, as would be the case if they were highly divergent.
It should also be noted that, in our analysis, we only
compared genome consensus sequences where each posi-
tion was defined by a single nucleotide. In reality, for any
sample, many nucleotide positions are represented by a
proportion of different nucleotides. In these cases, we took
the majority nucleotide as the consensus nucleotide and
did not attempt to delineate different populations in the
quasispecies. This means that, when comparing sequences,
we were only able to identify mutations throughout the
population of genomes and did not conclude that any or all
of these mutations were found in a single genomic RNA.
Phylogenetic analysis
Phylogenetic analysis of the six clinical samples described
here, based on the conserved RNA-dependent RNA
polymerase (RdRp), showed that they comprised a closely
related cluster (Fig. 4). As reported by Barker et al. (2013),
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Fig. 2. Agarose gel electrophoresis of PCR amplicons 1–7 (lanes 1–7, respectively) for tissue lesion samples 26M, 27C and
28O and faecal samples 65F, 67F and 80F. The 1 kbp DNA plus Ladder (Invitrogen) was used as molecular size markers and
the 1, 2, 3 and 6 kbp fragments are indicated.
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Fig. 3. Coverage of sequence reads across the assembled FCoV genomes from faecal and tissue lesion samples. Sequence
reads were aligned against the de novo assembled 80F target genome for the faeces-derived samples 80F, 65F and 67F and
the tissue lesion-derived samples 26M, 27C and 28O.
FCoV in cats with feline infectious peritonitis
http://vir.sgmjournals.org 1361
Downloaded from www.microbiologyresearch.org by
IP:  137.222.120.226
On: Mon, 18 Jan 2016 15:52:45
there was no evidence that the samples derived from FIP or
non-FIP animals represented genetically diverse co-cir-
culating strains, which provides further support for the
‘internal mutation’ hypothesis. However, it was very
difficult to exclude the possibility that at least some of
the mutations that may contribute to the development of
FIP were present in a minor component of the infecting
population, which was subsequently selected during virus
replication in vivo.
Comparison of FCoV genome sequences from
clinical samples
The genome sequences of the six FCoVs derived from
faecal and tissue lesion samples were translated into two
polyproteins (pp1a and pp1ab), four structural proteins (S,
M, N and E) and five accessory proteins (3s, 3b, 3c, 7a and
7b). We found that amino acid differences were located at
44 positions across an alignment of the six translatomes. At
21 of these positions, the differences fully or partially
discriminated between the genomes derived from faecal
(i.e. non-FIP) samples and from tissue (i.e. FIP) samples.
More specifically, in these 21 positions, one or more of the
translatomes from the FIP samples displayed an amino acid
that was not found at the corresponding position in the
translatomes from any of the non-FIP samples (Table 1).
We also identified deletions in the 3c protein ORF of
genomes from two of the FIP samples.
The fully discriminatory differences we identified were
located at two positions where a different amino acid was
found in all three FIP translatomes compared with all three
non-FIP translatomes. The first of these was at nt 23 302
and corresponded to the methionine-to-leucine substi-
tution identified by Chang et al. (2012). Thus, our data
support the idea that this substitution may be critical with
regard to the pathogenesis of FIP. The second fully
discriminatory substitution we identified, which was
present in all of the FIP samples but none of the non-FIP
samples, was at nt 23 486 and resulted in an isoleucine-to-
threonine substitution in the heptad repeat region 1 (HR1)
of the S2 domain in the FCoV S protein. The possible
significance of this substitution is discussed in more detail
below.
Apart from the fully discriminatory substitutions described
above, Table 1 shows a further 19 positions where one or
two of the translatomes from the FIP samples displayed an
amino acid that was not found at the corresponding
position in the translatomes from non-FIP samples.
Without any further information, it is difficult to conclude
that any of these substitutions, alone or in combination,
may be related to the development of FIP. However, they
should not be ignored. For example, the substitutions
resulting from mutations at nt 22 528 and 22 539 both lie
within the furin cleavage motif that separates the S1
(receptor-binding) and S2 (fusion) domains of the FCoV S
protein. Both substitutions (R789G at P4 and R792S at P1,
where P4 and P1 designate positions in the canonical furin
cleavage motif) would be predicted to alter furin cleavage
activity. If this is the case, our results support the con-
clusions of Licitra et al. (2013) who identified the furin
cleavage site as a potentially important region in the
development of FIP. Alternatively, it could be argued that
once the virus has acquired a tropism for the monocyte/
macrophage, cleavage at the furin recognition motif
may no longer be relevant to virus entry and mutations
may accumulate due to a lack of selection pressure. For
coronaviruses such as mouse hepatitis virus, cleavage at the
canonical furin motif does not seem to be essential, at least
for in vitro infectivity (Bos et al., 1997), and recent results
suggest that activation of the coronavirus S protein fusion
activity requires proteolytic cleavage at a different position
in the S2 subunit (Millet & Whittaker, 2014; Wicht et al.,
2014). Finally, Table 1 shows that two of the three
translatomes derived from the FIP samples had a deletion
in the 3c protein gene, which was not found in any of the
non-FIP samples. In both cases, the deletion of 10 nt led to
CCoV NTU336 GQ477367
FCoV 79-1146 DQ010921
FCoV NTU156 GQ152141
FCoV UU10 FJ938059
FCoV UU2 FJ938060
FCoV UU3 FJ938061
FCoV UU5 FJ938056
FCoV UU20 HQ39247.1
FCoV 26M KP143512
FCoV 27C KP143507
FCoV 280 KP143508
FCoV 65F KP143509
FCoV 67F KP143510
FCoV 80F KP143511
FCoV C1Je DQ848678
FCoV RM FJ938051
0.005
Fig. 4. Phylogenetic analysis of the core RdRp
domain of nsp12 (aa 4503–4807 in pp1ab,
Supplementary Fig. S1 available in the online
Supplementary Material) for FCoV strains
sequenced in this study and selected FCoV
genome sequences. The phylogenetic tree
was reconstructed by the neighbour-joining
method from an alignment made with CLUSTAL
W (MacVector). GenBank accession numbers
are shown for all sequences. Bootstrap values
exceeded 60% at all nodes. Bar, nucleotide
substitutions per site.
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a translational frameshift that produced a 3c protein
truncated 8 aa downstream of the deletion site.
In addition to amino acid substitutions that partially or
fully discriminated between the genomes derived from
non-FIP and FIP samples, our study also identified a
further 23 amino acid substitutions that did not discrim-
inate between non-FIP and FIP genomes. These are listed
in Table 2. These substitutions will not be discussed in
detail, but it is, perhaps, worth noting that the majority
Table 1. Amino acid substitutions that partially or fully
discriminate between the genome sequences derived from
non-FIP (faecal) and FIP (tissue lesion) samples
The positions of the substitutions are indicated as the position of the
relevant mutation/substitution based on alignment of the six FCoV
genomes analysed in this study (Supplementary Fig. S1). The amino
acid positions in the non-structural replicase proteins (nsps) refer to
pp1ab. The consensus nucleotide constituted more than 96% of the
sequence reads at a given position, unless indicated otherwise.
Nt
position
Protein 65F 67F 80F 26M 27C 28O Aa
position
1758 nsp2 I I I V V I 549
1794 nsp2 G G G G G R 561
6553 nsp3 D D D G G D 2147
14 727 nsp12 Y Y Y F* F* Y 4872
17 883 nsp14 T T T I I T 5924
19 277 nsp16 N ND N H H N 6389
21 370 S S S S A S S 403
21 377 S I I I I I T 405
22 291 S F F F F F L 710
22 361 S S S S I I S 733
22 528 S R R R G G R 789
22 539 S R R R R R S 792
22 757 S S S S F F S 865
23 302 S M M M L L L 1047
23 486 S I I I T T Td 1108
23 589 S K K K N N K 1142
24 190 S P P P P P S 1343
24 298 S E E E Q Q E 1379
25 447 3C T T T T T M 165
25 580–
25 589§
3C (2) (2) (2) (+) (+) (2) Deletion
27 228 N S S S L L S 170
28 759 7B L L L F L L|| 198
*The consensus nucleotide constituted 83% (26M) and 55% (27C) of
the sequence reads at this position.
DThe consensus nucleotide constituted 60% of the sequence reads at
this position.
dThe consensus nucleotide constituted 75% of the sequence reads at
this position.
§(2), 3c protein gene was complete; (+), 3c protein gene had a
deletion. The deletions were: 26M and 27C, nt 25584–25593 (10 nt,
AGGAGTTTAC).
||The consensus nucleotide constituted 85% of the sequence reads at
this position.
Table 2. Amino acid substitutions that do not discriminate
between the genome sequences derived from non-FIP (faecal)
and FIP (tissue lesion) samples
The positions of the substitutions are indicated as the position of the
relevant mutation/substitution based upon an alignment of the six
FCoV genomes analysed in this study (Supplementary Fig. S1). The
amino acid positions in the nsp proteins refer to pp1ab. The
consensus nucleotide constituted more than 96% of the sequence
reads at a given position, unless indicated otherwise.
Nt
position
Protein 65F 67F 80F 26M 27C 28O Aa
position
813 nsp2 V I I I I V 234
1794/1795 nsp2 E G G G G R 561
2955 nsp3 A T* T T T A 948
3082 nsp3 R KD K K K R 990
3797 nsp3 Q Q H Q Q Q 1228
5218 nsp3 V A A A A V 1702
5337 nsp3 L M M M M L 1742
6804 nsp3 A S A A A A 2231
8939 nsp5 K K N N N K 2942
14 564 nsp12 A A P P P A 4818
15 185 nsp13 I I L I I I 5025
20 509/
20 510
S A Pd L P P A 116
20 584 S D N N N N D 141
20 861 S S S§ N S S S|| 233
20 864 S R Q R Q Q R 234
20 866 S I L I I I L 235
21 275 S R R# Q R R R 371
21 467 S I T T T T I 435
22 151 S R K** K R R R 663
22332 S I IDD M I I I 723
27273 N L Q Q Q Q L 185
27873 7A H Ydd H Y Y H 6
*The consensus nucleotide constituted 71% of the sequence reads at
this position.
DThe consensus nucleotide constituted 72% of the sequence reads at
this position.
dThe consensus nucleotide constituted 71% of the sequence reads at
this position.
§The consensus nucleotide constituted 68% of the sequence reads at
this position.
||The consensus nucleotide constituted 85% of the sequence reads at
this position.
The consensus nucleotide constituted 71% of the sequence reads at
this position.
#The consensus nucleotide constituted 60% of the sequence reads at
this position.
**The consensus nucleotide constituted 59% of the sequence reads at
this position.
DDThe consensus nucleotide constituted 56% of the sequence reads at
this position.
ddThe consensus nucleotide constituted 78% of the sequence reads at
this position.
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were found either in the nsp3 protein or in the amino-
proximal S1 region of the S protein. This suggests that these
regions may represent the targets of particularly strong
selective pressures. In the case of the S1 region of the S
protein, we speculate that this selective pressure is immuno-
logical and relates to the production of neutralizing
antibodies. The selective pressures that target the nsp3
protein are unknown. For completeness, we also note that
we identified a single G-to-T mutation in the 39 UTR at
nt 28 926 of the consensus sequence derived from the 26M
sample that was not found in any other sample.
DISCUSSION
This study demonstrated an approach to the complete
genome sequencing of FCoVs derived from clinical
material that is achievable in a standard laboratory setting.
It was based on the generation of a virus-specific cDNA
library using oligonucleotide primer pairs, followed by
next-generation sequencing (NGS) on a commercial plat-
form, and downstream genome assembly using free software
that will run on a personal computer. This approach was
taken after we had failed to determine complete genome
sequences of FCoV from clinical samples using a randomly
primed cDNA library followed by NGS (Porter, 2014). In the
study reported here, complete genome sequencing was
achieved for six FCoVs using only seven primer pairs.
However, the samples we used were all collected within a few
months at a single location, which means that they were less
likely to have diverged compared with samples taken at
different locations over a longer time period. As the number
of complete genome sequences for both serotype 1 and
serotype 2 FCoVs increases, it may be possible to design a set
of universal primer pairs that will only require minor
optimization to successfully sequence any FCoV genome. In
our own laboratory, we have shown that the seven primer
pairs described here are able to produce amplicons of the
expected size in approximately two-thirds of geographically
divergent UK faecal samples collected over a 2-year period
(unpublished results).
In addition to confirming earlier findings, the most
interesting result of this study is undoubtedly the
identification of a consistent substitution of isoleucine
with threonine at aa 1108 in all FCoVs from FIP lesions
compared with the faecal samples from healthy cats. This
substitution is located within the heptad HR1 region of the
S2 subunit of the FCoV S protein and could be interesting
from two points of view. First, we note that this amino acid
position has been identified as being located in a major T-
helper 1 (Th1) epitope (I-S2-6, IGNITLALGKVSNAITTTSD)
in a type 1 Japanese FCoV (KU-2) that was associated with
FIP (Satoh et al., 2011). Obviously, further research will be
required to ascertain whether there is a Th1 epitope spanning
this amino acid sequence in non-FIP-associated FCoVs, and
to determine the quantitative or qualitative effect that
may result from the isoleucine-to-threonine substitution.
However, de Groot-Mijnes et al. (2005) have already drawn
attention to the relationship between T-cell depletion and the
enhanced virus replication in FIP cases, although the
mechanisms of T-cell depletion are not yet clear. We suggest
that this is an area of FIP research that merits further study.
For example, it would be interesting to compare IFN-c
production by PBMCs taken from cats with FIP or healthy
FCoV-infected cats, and exposed separately to relevant HR1
peptides, the sequences of which are derived from FIP- and
non-FIP-associated FCoVs.
Secondly, a quite different interpretation of the HR1
isoleucine-to-threonine substitution is that it may be related
to the fusogenic activity of the FCoV S protein. This is
because the substitution also lies within a stretch of 15 aa
[NAITT(I/T)SDGFNTMAS] that are found only in alpha-
coronaviruses and are part of the heptad repeat structure
that characterizes the HR1 region. Indeed, the isoleucine/
threonine position constitutes a residue predicted to be
located on the hydrophobic interface of the coiled-coil
structure. Substitution of a hydrophobic residue with a
polar, uncharged residue may, at least theoretically, signifi-
cantly influence the intercalation of HR1 and HR2 regions,
which is a necessary event during membrane fusion. It is also
worth noting that a very recent study by Bank-Wolf et al.
(2014) identified a position two residues downstream of the
isoleucine-to-threonine substitution where an aspartate resi-
due was found in all examined non-FIP-associated FCoVs (5/
5) butwas replaced by a tyrosine in a significant proportion (5/
9) of the FIP-associated FCoVs. Neither the isoleucine-to-
threonine nor aspartate-to-tyrosine substitutions consistently
discriminated between FIP and non-FIP FCoVs in the wider
alignment of 29 type 1 FCoV S protein amino acid sequences
that we examined (data not shown) but, again, we think they
may represent substitutions that are functionally related and
could be relevant to the development of FIP.
The comparative sequence approach taken by ourselves and
others has identified a number of potentially interesting
mutations in the coding sequences of non-FIP- and FIP-
associated FCoVs. In the future, this approach could be
extended, i.e. a larger collection of well-defined clinical
samples should be analysed, and it can be refined. For
example, to distinguish mutations that may relate to the
tropism of FCoVs from those that may relate to virulence, we
suggest it would be important to obtain sequence data from a
virus population that infects monocytes but is not able to
replicate at a high level. Clearly, obtaining appropriate clinical
samples (e.g. bloodmonocytes fromclinically healthy, FCoV-
infected cats) would not be easy, but it would be very
illuminating. The idea that a virus has to undergo sequential
mutation in vivo in order to cause a specific disease is not
unique to FIP (see, for example, the review on measles virus
pathogenesis by de Vries et al., 2012), but we suggest it
deserves closer attention in a number of veterinary and
human diseases.
Nevertheless, this sequencing approach is ultimately
limited. As has been stated before, compelling evidence
that any specific mutation in the FCoV genome is
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important for the development of FIP will require the use
of well-defined and characterized viruses produced by
reverse genetics and a valid experimental model of FIP.
With respect to reverse genetics, there are a number of
robust reverse genetics systems available for coronaviruses
in general, and for particular strains of FCoV (namely the
type 2 FCoV strain 79-1146 and the cell-culture-adapted
type1 FCoV strain Black) (Thiel et al., 2014). The pressing
need, however, is for a robust reverse genetics system that
can be applied to field strains of type 1 FCoV. In our
opinion, the bottleneck is not the molecular manipulation
of the FCoV genome but rather the ability to propagate
type 1 FCoVs in cell culture without extensive adaptation.
Although there has been recent progress in the development
of enterocyte cell lines that propagate type 1 FCoVs
(Desmarets et al., 2013), we believe that a more robust
cell-culture system that allows the propagation of high virus
titres and the rescue of both mutated and non-mutated
virus will be needed. To achieve this, identification of
both the cellular receptor and attachment factors specific to
type 1 FCoVs and the transduction of well-established,
continuous, feline cell lines that can easily be maintained will
be essential.
The second required element, a valid experimental model
of FIP, is also more challenging than it may at first appear.
For example, many of the commonly used animal models
of FIP often involve intraperitoneal inoculation. If the natural
course of FCoV infection involves sequential replication in
the gut, low-level replication in blood monocytes and high-
level replication in monocytes and macrophages, and each
transition is associated with the selection of specific mutants,
then this has to be reproduced in any valid experimental
model. In a recent report, Tekes et al. (2012) showed that
intraperitoneal infection of cats with a recombinant form of
the FCoV 79-1146 strain robustly induced FIP. Strikingly,
the virus reisolated from these cats demonstrated that there
had been strong selection for a virus that reverted to encode
an intact 3c protein. This is, in our view, good evidence that
FIP results from an infection that involves initial replication
in the gut.
In summary, our results contribute to a better under-
standing of FCoV genomic mutations that may or may not
be used as markers of the virus phenotype. It is also clear
from the results that the relationship between the viral
genotype and the development of FIP is complex. The
further analysis of complete FCoV genomes in defined
clinical samples, a robust reverse genetics system that can
be applied to field strains of serotype 1 FCoV and the
development of valid experimental models of FIP will all be
needed to throw further light on this relationship.
METHODS
Clinical samples and RNA extraction. The samples selected for this
study were faecal samples from three healthy kittens and post-mortem
tissue lesion samples from three kittens with FIP. These samples were all
obtained from a previously reported epizootic outbreak at a single-site
UK feline rescue centre (Barker et al., 2013). The three tissue lesion
samples, designated here as 26M (mesentery), 27C (colonic lymph
node) and 28O (omentum), were from cats F/FIP, Z/FIP and J/FIP in a
previous study (Barker et al., 2013) and had been collected within 2 h
of death, placed in RNAlater (Life Technologies) for 24–48 h at 4 uC
and then, after discarding the RNAlater, stored at 280 uC. The
diagnosis of FIP was confirmed by post-mortem examination including
histopathology and immunohistochemistry for the demonstration of
FCoV antigen in lesions (Kipar et al., 1998). The faecal samples (65F,
67F and 80F, previously named #65, #67 and#80) were collected from
the healthy cats within 1 month of euthanasia of the cats with FIP
(Barker et al., 2013). Samples 80F and 27C were from cats that were
littermates and were housed within the same pen. All three cats that
provided faecal samples remained alive and without any clinical signs
that could be suggestive of FIP for over 1 year post-sampling. Faecal
samples were stored at 280 uC immediately after collection.
Total RNA was extracted and purified from 20 mg tissue with a
NucleoSpin RNA kit (Macherey-Nagel) based on a previously
described method (Dye & Siddell, 2007; Dye et al., 2008). Briefly,
20 mg each tissue sample was disrupted in a 2 ml tube by adding
500 ml lysis buffer containing 1% b-mercaptoethanol (v/v) and a
5 mm stainless steel ball bearing. The sample was homogenized using
a TissueLyser II (Qiagen) at 30 Hz for 2 min and 470 ml lysate was
added to a filter column and centrifuged for 30 s at 10 000 g. A 350 ml
aliquot of the filtrate was added to 250 ml ethanol and run through a
binding column to which DNase I was added to remove genomic
DNA. Following multiple washes, the RNA was eluted into 50 ml
nuclease-free water. The NucleoSpin RNA kit was also used to extract
RNA from faecal samples using a method based on that described by
Dye et al. (2008). A faecal suspension was produced by vortexing
0.5 g faeces and 4.5 ml PBS five times for 30 s each. Subsequently,
100 ml of this suspension was centrifuged for 2 min at 10 000 g, and
the supernatant removed and added to 350 ml lysis buffer containing
1% b-mercaptoethanol (v/v). The protocol described above (from the
filter column) was then followed.
Histology and immunohistochemistry. Formalin-fixed tissue
samples (26M, 27C and 28O) were routinely paraffin wax embedded
and examined histologically to confirm the presence of typical FIP
lesions. The immunohistochemistry served to demonstrate FCoV
antigen within the lesions, as described previously (Kipar et al., 1998).
Quantitative RT-PCR (qRT-PCR) and virus-specific oligo-
nucleotide primer design. FCoV RNA was amplified from faecal
and tissue samples using qRT-PCR as described previously (Dye et al.,
2008; Porter et al., 2014). Oligonucleotide primer pairs (Table 3) were
designed to produce a total of seven RT-PCR products (amplicons)
spanning the entire coding region of the FCoV genome using the
MacVector Primer3 software package. Initially, the primers were
designed based on the genome sequence of FCoV C1Je, a serotype 1
FCoV (Dye & Siddell, 2007). The primers were then compared with
an alignment of 29 serotype 1 FCoV genome sequences (CLUSTAL W;
sequences available upon request) and optimized to allow for
sequence variation and compatibility of the primer pairs. All primers
were synthesized by Eurofins MWG Operon.
One-step RT-PCR. FCoV-specific primers were used to reverse
transcribe and amplify the viral RNA contained in 2 ml extracted total
RNA using a SuperScript III One-Step RT-PCR System with Platinum
Taq High Fidelity (Life Technologies) as described by the manufac-
turer. Briefly, a 50 ml reaction was set up on ice containing 2 ml RNA,
1 ml 10 mM forward and 1 ml 10 mM reverse primer, 25 ml 26
reaction mix (as supplied by the manufacturer), 2 ml SuperScript III
RT/Platinum High Fidelity enzyme mix and water to a final volume
of 50 ml. The reaction was incubated at 50 uC for 50 min to allow
cDNA synthesis, and then raised to 94 uC for 2 min, followed by 41
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cycles of 94 uC for 15 s, 50–66 uC (depending on the primer set) for
30 s and 68 uC for 1 min (kb of product size)21. The annealing
temperature for individual reactions was determined by the melting
temperature of the primers used. The reaction underwent a final
extension phase at 68 uC for 7 min and was held at 4 uC. For each
amplicon, 5 ml PCR product was separated on a 1% agarose/TBE gel
to confirm the PCR product size and to estimate the amount of DNA
by comparison with standards. The PCR products were then pooled
in approximately equimolar amounts and purified using Agencourt
AmPure XP beads (Agencourt AMPure XP PCR Purification;
Beckman Coulter), following the manufacturer’s protocol, and eluted
in nuclease-free water.
NGS. Purified, pooled amplicons were sequenced at the University of
Bristol Genomics Facility using the Ion Torrent platform (PGM with
a 316v2 chip). A targeted, virus-specific cDNA single-end read library
was produced. Briefly, DNA was fragmented using an Ion Xpress Plus
Fragment Library kit, ligated to Ion-compatible barcoded adaptors
and size-selected for a target read length of 150–200 bases. The library
was then amplified and purified using an Ion Plus Fragment Library
kit and an Agencourt AMPure XP kit. The barcoded libraries were
quantified and pooled in equimolar amounts using Bioanalyser
quantification. Templates were prepared from the barcoded, pooled
libraries using an Ion OneTouch 2 System. Routinely, four genomes
were sequenced on a single 316v2 chip.
Table 3. Sequences of oligonucleotide primers used in this study
Name Amplicon Sequence (5§A3§) Position of 5§ nucleotide in C1Je* Size (nt)
F169 1 TAGGAACGGGGTTGAGAG 169 18
R6507 1 GTGCGAGAACRGCCTTAA 6 473 18
F5562 2 GTTTGAAYTCACGTGGYCATT 5 511 21
R7490 2 GARGTCTTCATCWGAACCCAC 7 459 21
F6943 3 GCTAGTGTTAGAAATGTCTGTGTT 6 923 24
R12466 3 AAAAGCCCTACTAACGTGGTC 12 435 21
F12224 4 CATCCTGCAATTGAYGGATTG 12 173 21
R18105 4 TCCGGGTACATGTCTACGTTA 18 074 21
F17830 5 GATTGGTCCATTGTGTACCC 17 782 20
R20131b 5 AAARCCTTCCGATGACGAGGT 20 100 21
F19786b 6 GTATTAAGRAGATGGTTGCCA 19 735 21
R26007 6 ATAACCGCATGAGAAAAGGCT 25 813 21
F24798 7 TAAAATGGCCKTGGTATGTGT 24 601 21
R29508 7 TAGCTCTTCCATTGTTGGCTC 29187 21
*The positions of the oligonucleotides are given relative to the genome of FCoV C1Je (GenBank accession no. DQ848678).
Input raw data FASTQ files
Align sequence reads against
the 80F de novo assembled,
corrected target genome using
Bowtie2
Align sequence reads against
the de novo-assembled target
genome using Bowtie2
Select mapped reads (filter SAM)
80F and 27C
65F, 67F, 26M, 28O
Use IGV viewer to extract
consensus sequence from
the mapped reads. Correct
the consensus genome
sequence
Display target genome and
aligned reads in IGV and correct
the target genome sequence.
Confirm genome architecture
and ORFs consistent with
known FCoV genome
Trinity de novo assembly into
components
Assemble Trinity components in
MacVector assembly project
into single genome
Fig. 5. Sequence assembly workflow for FCoV genomes from faecal samples 65F, 67F, 80F and tissue lesion samples 26M,
27C, 28O.
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Bioinformatics. Sequence data were analysed using bioinformatics
tools including both de novo assembly (Trinity, http://trinityrnaseq.
github.io/) and genome alignment (Bowtie2, http://bowtie-bio.
sourceforge.net/bowtie2/index.shtml) methods. Briefly, for samples
80F and 27C, a de novo consensus sequence was produced from the
FASTQ reads using the Trinity assembled components and the
MacVector assembly project tool (Grabherr et al., 2011). In order to
identify and correct possible errors in this assembly, the same FASTQ
sequence files were then aligned with the assembled consensus
sequence using Bowtie2. The alignments were visualized using the
Integrative Genomics Viewer (IGV) and the consensus sequence was
manually corrected on the basis of the sequence reads. Subsequently,
the FASTQ sequence reads for four samples (65F, 67F, 26M and 28O)
were aligned with the corrected 80F consensus sequence using
Bowtie2. Again, IGV was used to confirm each consensus sequence
with regard to the relevant sequence reads. All of the assembled
genome sequences were examined and confirmed to have the
expected FCoV genome architecture and predicted ORFs. This
workflow is illustrated in Fig. 5. For selected viral genes, the encoded
protein sequences were derived and phylogenetic reconstruction was
done using a neighbour-joining algorithm based on an alignment
generated by CLUSTAL W (MacVector).
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